Literature DB >> 10604781

Sepsis: clinical dilemmas.

M J Murray1.   

Abstract

Sepsis, manifested by systemic inflammatory response syndrome (SIRS), septic shock and multiple organ dysfunction syndrome (MODS), remains the leading cause of morbidity and mortality in critically ill patients. Despite advances and our knowledge of sepsis, there remain clinical dilemmas that impact how we treat patients. These clinical dilemmas include hypotension, cardiac dysfunction and altered oxygen consumption. There is increasing recognition that treatment of these problems does not necessarily improve outcome. As we improve our understanding of sepsis, there is increased recognition that improvement in morbidity and survival will come not only from treating the manifestations of sepsis but also the endogenous mediators responsible for the development of these clinically important conditions. This manuscript discusses the clinical dilemmas associated with sepsis, current therapy and future directions for managing sepsis.

Entities:  

Mesh:

Year:  1998        PMID: 10604781      PMCID: PMC2578938     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  24 in total

1.  Hand-washing and nosocomial infections.

Authors:  D Goldmann; E Larson
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

Review 2.  The vascular endothelium in septic shock.

Authors:  J R Bradley; D Wilks; D Rubenstein
Journal:  J Infect       Date:  1994-01       Impact factor: 6.072

3.  Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?

Authors:  M Extermann; C Regamey
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

4.  Roundtable Conference on Clinical Trials for the Treatment of Sepsis. Brussels, March 12-14, 1994.

Authors:  W J Sibbald; J L Vincent
Journal:  Chest       Date:  1995-02       Impact factor: 9.410

Review 5.  The problem of sepsis. An expert report of the European Society of Intensive Care Medicine.

Authors: 
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Infection control and prevention strategies in the ICU.

Authors:  A F Widmer
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

7.  Effects of a nitric oxide synthase inhibitor in humans with septic shock.

Authors:  A Petros; G Lamb; A Leone; S Moncada; D Bennett; P Vallance
Journal:  Cardiovasc Res       Date:  1994-01       Impact factor: 10.787

8.  The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.

Authors:  P E Marik; M Mohedin
Journal:  JAMA       Date:  1994-11-02       Impact factor: 56.272

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Trends in infectious diseases mortality in the United States.

Authors:  R W Pinner; S M Teutsch; L Simonsen; L A Klug; J M Graber; M J Clarke; R L Berkelman
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

View more
  1 in total

1.  Sesamol ameliorates hypotension by modulating cytokines and PPAR-gamma in systemic inflammatory response.

Authors:  Srinivasan Periasamy; Pei-Yi Chu; Ya-Hui Li; Dur-Zong Hsu; Ming-Yie Liu
Journal:  EXCLI J       Date:  2015-08-13       Impact factor: 4.068

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.